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[57] ABSTRACT 
Thomte, 
A height referencing biochemical cassette comprising of a 
surface suitable to act as a coupling agent, a height refer 
encing indicator, and molecules bonded to the surface. This 
cassette is a capable of use to test for bonding to these 
molecules through measuring the height difference betWeen 
the indicator and the surface. This invention provides an 
efficient means to quickly and easily test for bonding of 
molecules to other molecules. 
26 Claims, No Drawings 
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HEIGHT REFERENCING BIOCHEMICAL 
CASSETTE 
CROSS-REFERENCE TO RELATED 
APPLICATION 
This application is a continuation of co-pending, com 
monly owned United States provisional application Ser. No. 
60/077,950 ?led Mar. 13, 1998, entitled THE BIOCHEMI 
CAL CASSETTE, AN ADDRESSABLE MACROMO 
LECULAR ARRAY, priority is claimed under 35 U.S.C. 
Section 120. 
GRANT REFERENCE CLAUSE 
This invention Was funded in part by a grant from the 
National Science Foundation, grant number DBI 9601789. 
The government may have certain rights in this invention. 
FIELD OF THE INVENTION 
The present invention relates to a bio chip and a method 
of making said bio-chip and a method of using said bio-chip 
to test for binding via height measurements. 
PROBLEMS IN THE ART 
Immunoassays play a critical role in clinical pharmaceu 
tical and environmental chemistries. Typically methodolo 
gies such as optical, amperometric, radiochemical, 
pieZoelectric, and capacitive mechanisms are used to detect 
antigen-antibody binding. HoWever, these methodologies 
generally require the use of labeled receptors, Which adds 
several preparative steps to the overall assay. Other dif? 
culties arise When using these other formats. For example, 
radiochemical immunoassays require stringent disposal pro 
cedures. Capacitive-based immunoassays provide perfor 
mance challenges in regard to orientation control of an 
immobiliZed receptor and the construction of extremely thin 
insulating layers for enhancing sensitivity. PieZoelectric 
devices are currently limited from the orientation of immo 
biliZed receptors and the response of these devices in liquid 
environments. 
Determination of adhesive strength bindings of antigen 
antibody interactions by atomic force microscopy (AFM) 
are typically affected by non-speci?c interactions betWeen a 
modi?ed probe tip in the sample surface. Another method 
ology utiliZing the AFM is topographic imaging. This 
approach relies on the change in the height that results from 
ligand-receptor binding and, therefore, does not require the 
use of labeled receptors. Generally height changes of 3—4 
nanometers are observed as a consequence of absorption of 
antigenic IgG to a surface, folloWed by a similar increase 
upon antibody-antigen binding. 
Therefore, it is a primary objective of the present inven 
tion to provide a neW type of bio-chip, termed the biochemi 
cal cassette or biocassette, Which overcomes or solves the 
problems and de?ciencies in the art. 
Another objective of the present invention is to provide a 
method of making the biochemical cassette. 
A further objective of the present invention is to provide 
a biochemical cassette Where large molecules can be depos 
ited at micron siZed addresses or even smaller. 
Another objective of the present invention is to provide a 
biochemical cassette that is easy to manufacture. 
Another objective of the present invention is to provide a 
biochemical cassette that may be easily measured to shoW 
topographic changes. 
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These and other features, objects, and advantages of the 
present invention Will become apparent to those skilled in 
the art to reference to the speci?cation and claims. The 
biochemical cassette is formed by placing a suitable cou 
pling agent to the cassette surface. The molecules are bound 
to the surface. 
Another embodiment is to provide a topographic point, 
plane, or array; Which is suitable in use for height referenc 
ing. 
A further embodiment is to place molecules of different 
compositions Within the roWs or arrays of the second 
embodiment. 
An immunoassay can then be performed using this bio 
cassette. An antibody may be bound as the molecule to the 
surface and topographis measurements are then taken. A 
change in height can be calculated from either prior mea 
surements of the cassette to the exposure of the solution, or 
the differences in height as indicated betWeen the reference 
point, plane, or arrays; and the height of the non-referencing 
surface folloWing exposure of the solution. A change in 
height indicates the formation of an antigen-antibody pair. 
Similar types of analyses can be accomplished using the 
change in topology. For example, chemical systems should 
not be limited solely to biological systems. 
SUMMARY OF THE INVENTION 
Abiochemical cassette, or biocassette can be easily manu 
factured and utiliZed by a topographical measurement to test 
for the bonding of molecules. Aheight referencing indicator 
alloWs for these measurements. 
Immunoassays can be performed using this biocassette 
When bonding antibodies in known surface locations. These 
immunoassays may be selected from the groups of proteins, 
protein fragments, antibodies, antibody fragments, DNA, 
DNA oligomers, and other chemically selective proteins and 
nucleic acids. The surface is then exposed to a solution and 
measurements are taken to indicate bonding. 
EXAMPLE OF AN EMBODIMENT 
The preferred method for constructing the biochemical 
cassette is comprised of ?ve steps. The ?rst step is the 
fabrication of the gold substrate. Besides gold, the surface of 
the biocassette may also be comprised of silicon, silver, 
platinum, carbon, copper, or mica. Namely, the surface must 
be solid and capable of being made smooth. The gold 
substrate fabrication utiliZes 10 mm><10 mm silicon Wafers 
((111) single crystals, manufactured by Montco Silicon). 
Other highly polished substrates Work Well. The silicon 
Wafers are precleaned in an ultrasonic bath for 30 minutes in 
Water and 30 minutes in ethanol. Next, the substrate is 
removed from the solution, dried using high-purity argon 
(available from Air Products) and placed in a vacuum 
evaporator (manufactured by EdWards). The substrate is 
then primed With a thin layer (15 nm) of chromium, at a rate 
of 0.1 nm/s, folloWed by the deposition of 300 nm of gold 
(99.99% purity), at a rate of 0.3—0.4 nm/s. The gold coated 
substrate is either used immediately upon removal from the 
evaporator, or stored under dry nitrogen. 
After fabricating the gold substrate, the second step 
involves the formation of the octadecanethiol (ODT) derived 
monolayer. Other coatings that have loW af?nities to non 
speci?c absorption, such as ?uorinated coating (e.g. PTFE) 
Work Well. The monolayer is formed by immersing the 
gold-coated substrates into dilute (1—10 mM) ethanolic 
solutions of recrystaliZed ODT (produced by Aldrich) for 
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approximately 24 hours. These samples are then rinsed 
extensively With ethanol (manufactured by Quantum, punc 
tilious grade) and dried under a stream of argon. 
The third step utilizes a patterning process. Mechanical, 
chemical, and Wet etching can accomplish this step. In this 
example, photopatterning is used. This process has been 
previously described in Tarlov, et al., Journal of the Ameri 
can Chemical Society 1993, 115, 5305. The patterns can be 
created, as an example, by sandWiching a copper transmis 
sion electron microscopy (TEM) grid (2000 mesh (hole siZe 
7.5 pm; bar siZe 5.0 pm))(manufactured by Electron Micros 
copy Sciences) betWeen an ODT coated sample and a quartZ 
plate. A 200-W, medium-pressure mercury lamp 
(manufactured by Oriel) is used as the light source. The light 
is collimated, re?ected off an air-cooled, dichroic mirror 
(220—260 nm), focused by a fused-silica lens, and passed 
through the TEM grid before impinging onto the sample. 
The sample is irradiated for approximately 20 minutes, With 
the poWer at the sample estimated at 550 mW/cm2. The 
photopatterning process converts the irradiated gold-bound 
thiolates to various forms of oxygenated sulfur (e.g., 
RSO3—). This conversion Was veri?ed using X-ray photo 
electron spectroscopy (XPS) and infrared re?ection 
absorption spectroscopy (IRRAS). The oxygenated forms of 
sulfur are readily removable by rinsing With most organic 
solvents. The use of AFM detected a height difference of 
approximately 2 nm betWeen the ODT layer in the grids and 
the uncoated gold in the squares. 
The fourth step entails removing the sulfonated part of the 
adlayer structure. In this example, it is done by rinsing With 
distilled, deioniZed Water (produced by Millpore) and With 
ethanol. After drying under a stream of argon, the samples 
are immediately immersed into a dilute (0.1—1 mM) ethan 
olic solution of DSU [dithiobis(succinimidyl undecanoatte)] 
for approximately 12 hours. DSU serves as a coupling agent 
for linking and containing molecules, including IgG, to the 
surface. Any kind of coupling chemistry Would be appro 
priate. For example, amine With antibodies, hydroxy groups, 
or carboxylic acids Would be available. The coupling agent 
should be capable of immobiliZing proteinaceous or pro 
teinic materials on the surface. Under these conditions there 
Was no detectable displacement of the ODT adlayer by 
solution-based DSU, as determined by IRRAS (detection 
limit, ~0.05 monolayer). The combination of steps 1—4 
produces a compositionally patterned surface With the DSU 
adlayer con?ned in the squares and the ODT adlayer con 
?ned in the grids. 
After steps 1—4 are completed, the presence of a compo 
sitional pattern on the surface, With a DSU adlayer con?ned 
in the squares, and an ODT adlayer con?ned in the grids, can 
be veri?ed using AFM imaging. AMultimode Nanoscope III 
AF M (manufactured by Digital Instruments), equipped With 
a 150-pm tube scanner Was used to obtain friction measure 
ments of the surface. The friction image (60 pm><60 pm) Was 
captured in a contact mode using 200 pm, oxide-sharpened, 
Si3N4 cantilevers (available from Nanoprobes) With normal 
bending and torsional force constants of approximately 0.06 
and 80 N/m, respectively. The friction image Was obtained 
With a load or normal force of approximately 25 nN While 
the AFM chamber Was continuously purged With dry nitro 
gen. 
The friction image shoWed a surface composed of a 
periodic array of squares and grids, the squares having a 
higher friction than the grids. The grids Were approximately 
5 pm Wide, and the squares Were approximately 7.5 pm 
Wide, Which are consistent With the photopatterning process 
described earlier. The difference betWeen the friction of the 
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squares and of the grids is consistent With the knoWn 
difference betWeen the friction of an ODT layer and the 
friction of a DSU layer. 
Once the compositionally patterned surface (steps 1—4) is 
formed, the ?fth and ?nal step consists of covalent immo 
biliZation of rabbit IgG. Polyclonal rabbit IgG 
(manufactured by Pierce) is used. Covalent immobiliZation 
is achieved by immersing the compositionally patterned 
samples into a 50 mM Delbucco’s phosphate buffer (PBS) 
(available from Life Technologies) at a pH of 6.0 With the 
addition of 1% (v/v) TWeen®80 (polyethylenesorbitan 
monooleate) (manufactured by Aldrich) and 1 mg/mL anti 
body. TWeen®80 minimiZes nonspeci?c binding of IgG onto 
the surface. The acyl carbon of the succinimidyl ester group 
of DSU is very susceptible to nucleophilic attack by primary 
amine-containing compounds (i.e., lysine residues of a 
protein), resulting in the formation of an amide linkage. The 
large number of lysine residues that are distributed through 
out the IgG structure lead to its bonding With DSU, immo 
biliZing the IgG. 
Both AFM imaging and ?uorescent imaging Were used to 
ensure that a spatially patterned array of immobiliZed rabbit 
IgG had been formed. An AFM topographic image and a 
friction image (both 40 pm><40 pm) of a patterned surface 
that had been formed using steps 1—5 Were acquired under 
dry nitrogen at a load or normal force of approximately 2 
nN. The height of the rabbit IgG adlayer in the squares Was 
3—4 nm larger than the ODT adlayer in the grids. This height 
differential indicates a successful creation of a patterned 
array of antibodies. The difference in friction Was also 
consistent With the expected differences in the composition 
of the tWo components for the patterned surface. 
Fluorescent images Were acquired using an Odyssey 
confocal scanning laser microscope (manufactured by 
Noran Instruments) in combination With an Axiovert 135 
inverted microscope (produced by Zeiss). Solutions contain 
ing goat anti-rabbit IgG and goat anti-bovine IgG samples 
Were used in the ?uorescent images. These solutions con 
tained 0.1 mg/mL of the particular antibody in a “binding 
buffer” composed of 100 mM Tris-HCl (pH 7.6), 100 mM 
NaCl, 15 mM magnesium chloride, and 1% (v/v) TWeen 80. 
Other compositions of a binding buffer can also be used. 
Any solution required to get binding to Work Would be 
appropriate. The goat anti-rabbit and goat anti-bovine IgG 
Were conjugated With ?uorescein isothiocyanate (FITC). All 
of the reagents are manufactured by Sigma. 
For the ?uorescence experiments, the immobiliZed rabbit 
IgG arrays Were incubated in binding buffer containing the 
FITC-tagged secondary antibody for approximately 12 
hours. After being removed from the buffer solution, the 
samples Were rinsed With copius amounts of deioniZed Water 
and dried under a stream of argon. The samples Were 
protected from light during all preparation steps prior to 
imaging. The images Were acquired using samples 
immersed in deioniZed Water. Image collection folloWed a 
tWo-step process. First, bright-?eld images Were acquired to 
establish a focal plane on the sample surface to minimiZe 
sample photobleaching. Second, 16 confocal ?uorescence 
images Were collected and averaged using 488-nm excita 
tion a 515-nm loW-pass barrier ?lter (rejection at 488 nm, 
4><10_4) , and a 25 pm slit Width. 
The ?uorescent image of the immobiliZed rabbit IgG that 
Was incubated With the goat anti-rabbit antibody tagged With 
FITC exhibited a pattern of ?uorescent 7.5 pm squares 
separated by non?uorescent grids. This image indicates that 
step 5 results in the immobiliZation of an array of viable 
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rabbit IgG and that there is no nonspeci?c adsorption of the 
FITC-tagged antibody on the grids. The lack of nonspeci?c 
adsorption on the grids is attributable to the presence of the 
TWeen 80 surfactant in the buffer solution along With the 
hydrophobicity of ODT. The absence of nonspeci?c adsorp 
tion alloWs the adlayer to serve as an internal reference plane 
for measuring height changes. 
A?uorescent image of an immobilized array of rabbit IgG 
that had been eXposed to the goat anti-bovine secondary 
antibody tagged With FITC Was also obtained. The ?uores 
cent image appeared dark under the same illumination 
conditions that Were used to vieW the other ?uorescent 
image. This indicates a lack of any detectable nonspeci?c 
adsorption of the goat anti-bovine IgG at the patterned array. 
The tWo images together support the construction of a 
viable, compositionally patterned array of covalently immo 
biliZed rabbit IgG antibodies that can be utiliZed for an 
AFM-based immunoassay. 
An AFM height image (40 pm><40 pm) of a rabbit IgG 
array in 50 mM PBS and 1% (v/v) TWeen 80 Was obtained. 
This image Was compared to an AFM height image obtained 
of the patterned array of rabbit IgG that Was eXposed to a 
solution containing 0.1 mg/mL goat anti-rabbit IgG in 
binding buffer composed of 100 mM Tris-HCl (pH 7.6), 100 
mM NaCl, 15 mM magnesium chloride, and 1% (v/v) TWeen 
80. Both images Were obtain at a load or normal force of of 
approximately 2 nN. The comparison of the images shoWed 
that the height of the squares, measured relative to that of the 
ODT adlayer in the grids, effectively doubles upon the 
introduction of the solution containing the speci?c second 
ary antibody. In addition, real time monitoring shoWs that 
the height increase appears to be complete Within 5 minutes, 
indicating that the binding betWeen the immobiliZed antigen 
and solution based antibody occurs rapidly. Overall, these 
results are diagnostic of the rapid formation of complemen 
tary antigen-antibody pairs Within each of the IgG modi?ed 
elements of the array. 
A third AFM height image, of an array of rabbit IgG that 
Was eXposed to a solution containing 0.1 mg/mL goat 
anti-bovine IgG in binding buffer composed of 100 mM 
Tris-HCl (pH 7.6), 100 mM NaCl, 15 mM magnesium 
chloride, and 1% (v/v) TWeen 80, Was also obtained. The 
height difference betWeen the squares and the grids is 
indistinguishable before and after the eXposure of the immo 
biliZed array of rabbit IgG to the solution of goat anti-bovine 
IgG. This image indicates that the height changes that Were 
observed When the rabbit IgG array Was eXposed to the goat 
anti-rabbit IgG Were due to speci?c binding and not non 
speci?c binding. The combined Weight of the three AFM 
height images demonstrates the potential for microminiatur 
iZed immunoassays using AFM. 
By depositing various antibodies at knoWn locations on 
the biochemical cassette, large scale immunoassays could be 
performed in a short time period. Atypical AF M can scan an 
area of more than 100 pm2 in 1—5 minutes. Thus, for the 
biochemical cassette described here, With 5 pm squares and 
2 pm Wide grid bars, the AFM could interrogate approXi 
mately 200 individual addresses in a feW minutes. 
In addition to the above results, a preliminary study 
supports the possible regeneration and reuse of the bio 
chemical cassette. The eXperiment Was conducted by rinsing 
a rabbit IgG array that Was coupled to goat anti-rabbit IgG 
With a solution of 100 mM glycine-HCl (pH 2.4). This 
processing effectively breaks the antigen-antibody pair and 
leaves the rabbit IgG array intact for potential reuse. Topo 
graphic imaging after eXposure to the glycine-HCl solution 
shoWed the original rabbit IgG array Was still present. 
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What is claimed is: 
1. A biocassette, said biocassette providing an internal 
reference plane for the detection of topographic changes, 
formed by the process of: 
5 fabricating a surface that can be made smooth; 
patterning the surface to form a periodic array of coated 
surfaces and uncoated surfaces, Whereby a hydrophobic 
monolayer is con?ned on the coated surfaces, said 
monolayer serving as a height referencing indicator; 
applying a coupling agent to the patterned surface to form 
an adlayer of coupling agent on the uncoated surfaces, 
said coupling agent being capable of immobiliZing 
proteinaceous materials or nucleic acids; and 
immobiliZing at least one protein or nucleic acid on the 
adlayer. 
2. The biocassette of claim 1, Wherein the protein or 
nucleic acid is selected from the group consisting of 
proteins, protein fragments, antibodies, antibody fragments, 
DNA, and nucleic acids. 
3. The biocassette of claim 1, Wherein the surface is 
selected from the group consisting of gold (Au), silicon (Si), 
silver (Ag), platinum (Pl), carbon (C), copper (Cu), and 
mica. 
4. The biocassette of claim 1, Where in the monolayer 
eXhibits nonspeci?c absorption. 
5. The biocassette of claim 1 Wherein the monolayer 
comprises ODT. 
6. The biocassette of claim 1 Wherein the coupling agent 
is selected from the group consisting of DSU, amine With 
antibodies, hydroXy groups, and carboXylic acids. 
7. The biocassette of claim 1 Wherein the coupling agent 
is DSU. 
8. The biocassette of claim 1 Wherein the immobiliZing 
step comprises immersing the patterned surface into a solu 
tion comprising a buffer and a surfactant. 
9. The biocassette of claim 8 Wherein the surfactant is 
polyethylenesorbitan monooleate. 
10. A method of making a biocassette, said biocassette 
providing an internal reference plane for the detection of 
topographic changes, comprising: 
fabricating a surface that can be made smooth; 
patterning the surface to form a periodic array of coated 
surfaces and uncoated surfaces, Whereby a hydrophobic 
monolayer is con?ned on the coated surfaces, said 
monolayer serving as a height referencing indicator; 
applying a coupling agent to the patterned surface to form 
an adlayer of coupling agent on the uncoated surfaces, 
said coupling agent being capable of immobiliZing 
proteinaceous materials or nucleic acids; and 
immobiliZing at least one protein or nucleic acid on the 
adlayer. 
11. The method of claim 10, Wherein the protein or 
nucleic acid is selected from the group consisting of 
proteins, protein fragments, antibodies, antibody fragments, 
DNA, and nucleic acids. 
12. The method of claim 10, Wherein the monolayer 
eXhibits nonspeci?c absorption. 
13. The method of claim 10, Wherein the indicator com 
prises an array. 
14. The method of claim 13, Wherein the array is created 
via photopatterning. 
15. The method of claim 10 Wherein the surface is 
patterned using a method selected from the group consisting 
of mechanical, chemical, and Wet etching. 
16. A biocassette, said biocassette providing an internal 
reference plane for the detection of topographic changes, 
comprising: 
20 
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a surface patterned to form a periodic array of coated 
surfaces and uncoated surfaces, Whereby a hydrophobic 
monolayer is con?ned on the coated surfaces, said 
monolayer serving as a height referencing indicator; 
an adlayer of coupling agent on the uncoated surfaces, 
said coupling agent being capable of immobilizing 
proteinaceous materials or nucleic acids; and 
at least one immobilized protein or nucleic acid on the 
adlayer. 
17. The biocassette of claim 16, Wherein the protein or 
nucleic acid is selected from the group consisting of 
proteins, protein fragments, antibodies, antibody fragments, 
DNA, and nucleic acids. 
18. The biocassette of claim 16, Wherein the surface is 
selected from the group consisting of gold (Au), silicon (Si), 
silver (Ag), platinum (Pl), carbon (C), copper (Cu), and 
mica. 
19. The biocassette of claim 16, Where in the monolayer 
eXhibits nonspeci?c absorption. 
20. The biocassette of claim 16 Wherein the monolayer 
comprises ODT. 
21. The biocassette of claim 16 Wherein the coupling 
agent is selected from the group consisting of DSU, amine 
With antibodies, hydroXy groups, and carboXylic acids. 
22. The biocassette of claim 16 Wherein the surface is 
gold. 
23. The biocassette of claim 16 Wherein the uncoated 
surfaces have a higher friction than the coated surfaces. 
8 
24. A biocassette, said biocassette providing an internal 
reference plane for the detection of topographic changes, 
comprising: 
a surface patterned to form a periodic array of coated 
surfaces and uncoated surfaces, Whereby an ODT 
monolayer is con?ned on the coated surfaces, said 
monolayer serving as a height referencing indicator; 
an adlayer of DSU on the uncoated surfaces; and 
at least one immobiliZed protein or nucleic acid on the 
adlayer. 
25. A method of making a biocassette, said biocassette 
providing an internal reference plane for the detection of 
topographic changes, comprising: 
fabricating a surface that can be made smooth; 
patterning the surface to form a periodic array of coated 
surfaces and uncoated surfaces, Whereby an ODT 
monolayer is con?ned on the coated surfaces, said 
monolayer serving as a height referencing indicator; 
applying DSU to the patterned surface to form an adlayer 
of coupling agent on the uncoated surfaces, said cou 
pling agent being capable of immobiliZing proteina 
ceous materials or nucleic acids; and 
immersing the patterned surface With the adlayer of 
coupling agent into a buffer solution comprising a 
protein or nucleic acid and a surfactant. 
26. The method of claim 25 Wherein the surfactant is 
polyethylenesorbitan monooleate. 
* * * * * 
